Oral triiodothyronine
164/H2.F1/ETIK/2013
Phase 3 small_molecule completed
Quick answer
Oral triiodothyronine for Postoperative; Dysfunction Following Cardiac Surgery is a Phase 3 program (small_molecule) at Cardiff Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cardiff Oncology
- Indication
- Postoperative; Dysfunction Following Cardiac Surgery
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed